A world-first clinical trial launched in Melbourne is being hailed as a "game-changer" for its potential to revolutionize the ...

The answer to this inquiry is “yes” — but maybe “no.” Will confidentiality agreements shield any prior art concerns? Once ...

As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA ...

Tresidder said his Melbourne-based firm has “a real focus” on biotech and life sciences. He sketched some of the ways brokers ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

Casemiro has had its trials and tribulations at Man Utd over the past two years but the Brazilian has enjoyed a renaissance ...

In a dynamic environment, an expert shares insights into potential AI applications in the clinical research setting at OCT ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their families, including in the D.C. area.

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...